Real-time enrollment status for this lung cancer clinical trial
Current Status
Unknown
Checked: March 2, 2026 at 10:16 AM UTC
| NCT Number | NCT05068024 |
| Recruiting Status | Unknown |
| Condition | Lung Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Forward Pharmaceuticals Co., Ltd. |
| Last Updated on CT.gov | July 26, 2022 (Jul 26, 2022) |
As of March 2, 2026: Clinical trial NCT05068024 is currently unknown participants. This clinical trial study for lung cancer is not currently accepting new participants at 2 locations across the United States. The study is sponsored by Forward Pharmaceuticals Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05068024 is currently unknown. The study may resume recruiting in the future.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05068024 was last updated Jul 26, 2022 (July 26, 2022). HelloStudys verifies this status automatically.